NKTR Overview
Upcoming Projects (NKTR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (NKTR)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (NKTR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (NKTR)
-
Nektar (NKTR), Bristol-Myers (BMY) to end development program for bempegaldesleukin/Opdivo
Tickers: BMY, NKTR
Occurred on: Apr 14, 2022 -
FDA delays Nektar Therapeutics' (NKTR) marketing application for NKTR-181 opioid in lower back pain
Ticker: NKTR
Occurred on: Aug 30, 2019 -
Phase 1b data of Nektar Therapeutics'(NKTR) NKTR-358 in Systemic lupus erythematosus (SLE) due at EULAR June 13, 2019
Ticker: NKTR
Occurred on: Jun 13, 2019 -
Phase 1/2 preliminary results of NKTR-214 (PEG-rhuIL-2) in combination with nivolumab in advanced solud tumors (PIVOT trial)
Tickers: NKTR, BMY
Occurred on: Jun 02, 2018 -
Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia Phase 3 Study Completed
Ticker: NKTR
Occurred on: May 07, 2017 -
Nektar (NKTR) Reports Phase 3 SUMMIT-07 Data Evaluating NKTR-181 in Chronic Low Back Pain
Ticker: NKTR
Occurred on: Mar 20, 2017 -
Bayer Phase 3 program called RESPIRE of Cipro DPI (Cipro Dry Powder Inhaler) for Non-cystic fibrosis bronchiectasis data due 2H 2016
Ticker: NKTR
Occurred on: Nov 24, 2016
Strategic Initiatives (NKTR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
